Table 3.
Organism | Drug | Duration | Alternative/Comments |
---|---|---|---|
Oxacillin-sensitive Staphylococcus | oxacillin/nafcillin 2g IV q4h PLUS rifampin 300 mg IV/PO q8h PLUS gentamicin 1 mg/kg IV/IM q8ha |
≥ 6 weeks ≥6 weeks 2 weeks |
For non-anaphylactoid penicillin allergy, substitute cefazolin 2g IV q8h for oxacillin/nafcillin. For anaphylactoid penicillin allergy, substitute vancomycin 15 mg/kg IV q12hb for oxacillin/nafcillin |
Oxacillin-resistant Staphylococcus | vancomycin 15 mg/kg IV q12hb PLUS rifampin 300 mg IV/PO q8h PLUS gentamicin 1 mg/kg IV/IM q8ha |
≥6 weeks ≥6 weeks 2 weeks |
|
Viridans streptococci/S. bovis with penicillin MIC ≤ 0.12 μg/mL | penicillin G 24 million U IV per 24hc WITH OR WITHOUT gentamicin 3 mg/kg IV/IM q24h OR ceftriaxone 2g IV/IM q24h WITH OR WITHOUT gentamicin 3 mg/kg IV/IM q24h |
6 weeks 2 weeks 6 weeks 2 weeks |
For penicillin/ceftriaxone allergy, vancomycin 15 mg/kg q12hb for 6 weeks without gentamicin |
Viridans streptococci/S. bovis with penicillin MIC > 0.12 | penicillin G 24 million U IV per 24hc PLUS gentamicin 3 mg/kg IV/IM q24h OR ceftriaxone 2g IV/IM q24h PLUS gentamicin 3 mg/kg IV/IM q24h |
6 weeks 6 weeks 6 weeks 6 weeks |
For penicillin/ceftriaxone allergy, vancomycin 15 mg/kg q12hb for 6 weeks without gentamicin |
Enterococcus spp. | PVE treatment regimens identical to NVE treatment regimens. See Table 2. |
- | - |
target gentamicin peak 3–4 micrograms/mL; target trough <1 microgram/mL
target vancomycin peak 30–45 micrograms/mL; target trough 10–15 micrograms/mL
penicillin dosing can be by continuous infusion, or dosed q4-6h in equal divided doses adapted with permission from Baddour LM et al [40]